These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27987595)

  • 1. Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer.
    Halvorsen TO; Herje M; Levin N; Bremnes RM; Brustugun OT; Fløtten Ø; Kaasa S; Sundstrøm S; Grønberg BH
    Lung Cancer; 2016 Dec; 102():9-14. PubMed ID: 27987595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
    Grønberg BH; Halvorsen TO; Fløtten Ø; Brustugun OT; Brunsvig PF; Aasebø U; Bremnes RM; Tollåli T; Hornslien K; Aksnessæther BY; Liaaen ED; Sundstrøm S;
    Acta Oncol; 2016 May; 55(5):591-7. PubMed ID: 26494411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
    Morimoto M; Okishio K; Akira M; Omachi N; Tamiya A; Asami K; Kawaguchi T; Atagi S
    Clin Lung Cancer; 2017 Mar; 18(2):e117-e127. PubMed ID: 28340925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
    Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
    Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
    Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
    J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal lung tumor volume changes in small-cell lung cancer patients undergoing chemoradiotherapy.
    Yee D; Rathee S; Robinson D; Murray B
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):142-7. PubMed ID: 20646851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
    Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.
    Okamoto K; Okamoto I; Takezawa K; Tachibana I; Fukuoka M; Nishimura Y; Nakagawa K
    Jpn J Clin Oncol; 2010 Jan; 40(1):54-9. PubMed ID: 19837690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.
    Valan CD; Slagsvold JE; Halvorsen TO; Herje M; Bremnes RM; Brunsvig PF; Brustugun OT; Fløtten Ø; Levin N; Sundstrøm SH; Grønberg BH
    Anticancer Res; 2018 Feb; 38(2):871-876. PubMed ID: 29374714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
    Sun JM; Ahn YC; Choi EK; Ahn MJ; Ahn JS; Lee SH; Lee DH; Pyo H; Song SY; Jung SH; Jo JS; Jo J; Sohn HJ; Suh C; Lee JS; Kim SW; Park K
    Ann Oncol; 2013 Aug; 24(8):2088-92. PubMed ID: 23592701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
    Bayman E; Etiz D; Akcay M; Ak G
    Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
    Bogart JA; Herndon JE; Lyss AP; Watson D; Miller AA; Lee ME; Turrisi AT; Green MR;
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):460-8. PubMed ID: 15145163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
    Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
    Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
    van Loon J; Offermann C; Ollers M; van Elmpt W; Vegt E; Rahmy A; Dingemans AM; Lambin P; De Ruysscher D
    Radiother Oncol; 2011 May; 99(2):172-5. PubMed ID: 21571382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.
    Hu X; Bao Y; Xu YJ; Zhu HN; Liu JS; Zhang L; Guo Y; Jin Y; Wang J; Ma HL; Xu XL; Song ZB; Tang HR; Peng F; Fang M; Kong Y; Chen MY; Dong BQ; Zhu L; Yu C; Yu XM; Hong W; Fan Y; Zhang YP; Chen PC; Zhao Q; Jiang YH; Zhou XM; Chen QX; Sun WY; Mao WM; Chen M
    Cancer; 2020 Feb; 126(4):840-849. PubMed ID: 31714592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
    Misumi Y; Okamoto H; Sasaki J; Masuda N; Ishii M; Shimokawa T; Hosomi Y; Okuma Y; Nagamata M; Ogura T; Kato T; Sata M; Otani S; Takakura A; Minato K; Miura Y; Yokoyama T; Takata S; Naoki K; Watanabe K
    BMC Cancer; 2017 May; 17(1):377. PubMed ID: 28549414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
    van Loon J; De Ruysscher D; Wanders R; Boersma L; Simons J; Oellers M; Dingemans AM; Hochstenbag M; Bootsma G; Geraedts W; Pitz C; Teule J; Rhami A; Thimister W; Snoep G; Dehing-Oberije C; Lambin P
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):329-36. PubMed ID: 19782478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
    Amin NP; Miften M; Kavanagh B; Raben D; Camidge DR; Thornton D; Rochford N; Gaspar LE
    J Thorac Oncol; 2011 Sep; 6(9):1553-62. PubMed ID: 21642862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study.
    Xenidis N; Kotsakis A; Kalykaki A; Christophyllakis Ch; Giassas S; Kentepozidis N; Polyzos A; Chelis L; Vardakis N; Vamvakas L; Georgoulias V; Kakolyris S
    Lung Cancer; 2010 Jun; 68(3):450-4. PubMed ID: 19783319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.